Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction.

Overview

It will be evaluated the clinical efficacy of Diclofenac 50mg (NSAID) compared to its association with Codeine 50mg (opioid) administered in 50 patients requiring extraction of two third molars. After assessing the research parameters, a comparative data analysis, along with the proper application of statistical tests, will provide the basis for an evaluation of both efficiency medications used.

Full Title of Study: “Effectiveness of Non-steroidal Anti-inflammatory Diclofenac and Its Association to the Opioid Codeine for Pain, Swelling and Trismus in the Bilateral Mandibular Third Molar Extraction With a High Degree of Difficulty Model.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: June 2015

Detailed Description

This research will evaluate the clinical efficacy of Diclofenac 50mg (NSAID) compared to its association with Codeine 50mg (opioid) administered in 50 patients aged less than 18 and requiring extraction of two third molars (with very similar positions, whose degree of difficulty is high). It will be assessed the following parameters: 1) onset and duration of surgery after administration of local anesthetic, 2) open mouth prior to surgery, on the 2nd day after the operation and on the 7th day after surgery (removal points), 3) subjective assessment of pain using a visual analog scale, 4) measurement of facial edema in the second day after the operation and on the 7th day after surgery (as compared with the measurements obtained before surgery) and 5) the incidence, type and severity of adverse reactions. The analysis comparative data, along with the proper application of statistical tests, provide the basis for an evaluation of both efficiency medications used.

Interventions

  • Drug: Codeine + Diclofenac
    • The patients will receive codeine and diclofenac as pain relief medicine after the surgery
  • Drug: Diclofenac
    • The patients will receive only diclofenac

Arms, Groups and Cohorts

  • Experimental: Pain control using codeine + diclofenac
    • Fifty healthy volunteers underwent removal of symmetrically positioned lower third molars, receiving for pain relief after the procedure 50mg of codeine + 50mg of diclofenac
  • Experimental: Pain control using diclofenac
    • Fifty healthy volunteers underwent removal of symmetrically positioned lower third molars, receiving for pain relief after the procedure 50mg of diclofenac

Clinical Trial Outcome Measures

Primary Measures

  • Higher pain control after lower third molar surgeries with codeine + diclofenac
    • Time Frame: Seven days after surgery
    • Reducing pain is measured by visual analogue scale. It is expected that the visual analogue scale (100 mm) presents lower values in patients that underwent surgeries and received the association of codeine + diclofenac compared to whose received only diclofenac. Evaluated periods were 0, 15, 30, 45 min, 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 48, 72 and 96 hours.

Secondary Measures

  • Adverse effects
    • Time Frame: Seven days after surgery
    • Increased reporting of adverse effects during the postoperative period in patients that received codeine + diclofenac assessed by the information contained in the medical records of the patient.

Participating in This Clinical Trial

Inclusion Criteria

  • Impacted lower third molar – not in use of NSAID or opioids in the last one month Exclusion Criteria:

  • Local anesthetics allergy, – History of gastrointestinal bleeding or ulcers, – Kidney disease, – Asthma, – Allergy or sensitivity to aspirin or any other NSAID or opioids, – Pregnant or nursing woman, – Patients using antidepressant, diuretic or aspirin, – Patients under treatment to quit drugs

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Sao Paulo
  • Collaborator
    • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
  • Provider of Information About this Clinical Study
    • Principal Investigator: Paulo Zupelari Goncalves, DDS. – University of Sao Paulo
  • Overall Official(s)
    • Paulo Z Goncalves, DDS, Study Chair, Bauru School of Dentistry – University of Sao Paulo – USP

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.